REGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorMartin Broto, J.
dc.contributor.authorValverde, C.
dc.contributor.authorHindi, N.
dc.contributor.authorVincenzi, B.
dc.contributor.authorMartinez-Trufero, J.
dc.contributor.authorGrignani, G.
dc.contributor.authorItaliano, A.
dc.contributor.authorLavernia, J.
dc.contributor.authorGonzalez-Campora, R.
dc.contributor.authorVallejo, A.
dc.contributor.authorHernandez-Jover, D.
dc.contributor.authorGutierrez, A.
dc.contributor.authorSerrano, C.
dc.contributor.authorMoura, D.
dc.contributor.authorLopez-Guerrero, J. A.
dc.contributor.authorCruz, J.
dc.contributor.authorFernandez-Serra, A.
dc.contributor.authorBlay, J-Y.
dc.contributor.authorFumagalli, E. R.
dc.contributor.authorMartinez Marin, V.
dc.contributor.authoraffiliation[Martin Broto, J.] Fdn Jimenez Diaz Univ Hosp, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Hindi, N.] Fdn Jimenez Diaz Univ Hosp, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Valverde, C.] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Vincenzi, B.] Univ Campus Biomed, Med Oncol, Rome, Italy
dc.contributor.authoraffiliation[Martinez-Trufero, J.] HU Miguel Servet, Med Oncol, Zaragoza, Spain
dc.contributor.authoraffiliation[Grignani, G.] FPO IRCCS, Candiolo Canc Inst, Div Med Oncol, Turin, Italy
dc.contributor.authoraffiliation[Italiano, A.] Inst Bergonie, Med Oncol, Bordeaux, France
dc.contributor.authoraffiliation[Lavernia, J.] Fdn IVO, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Cruz, J.] Fdn IVO, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Gonzalez-Campora, R.] Hosp Quironsalud Cordoba, Pathol, Cordoba, Spain
dc.contributor.authoraffiliation[Vallejo, A.] HU Virgen Macarena, Pathol, Seville, Spain
dc.contributor.authoraffiliation[Hernandez-Jover, D.] HU St Pau, Radiol, Barcelona, Spain
dc.contributor.authoraffiliation[Gutierrez, A.] HU Son Espases, Hematol, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Serrano, C.] Vall dHebron Inst Oncol VHIO, Sarcoma Translat Res, Barcelona, Spain
dc.contributor.authoraffiliation[Moura, D.] CITIUS III, ATBsarc Grp, Seville, Spain
dc.contributor.authoraffiliation[Lopez-Guerrero, J. A.] Fdn IVO, Mol Biol, Valencia, Spain
dc.contributor.authoraffiliation[Fernandez-Serra, A.] Fdn IVO, Mol Biol, Valencia, Spain
dc.contributor.authoraffiliation[Blay, J-Y.] Ctr Leon Berard, Dept Med, Lyon, France
dc.contributor.authoraffiliation[Fumagalli, E. R.] Fdn IRCCS Ist Nazl Tumori, Dept Med, Milan, Italy
dc.contributor.authoraffiliation[Martinez Marin, V.] Hosp Univ La Paz, Med Oncol, Madrid, Spain
dc.contributor.funderBayer
dc.date.accessioned2025-01-07T16:06:16Z
dc.date.available2025-01-07T16:06:16Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.850
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.850
dc.identifier.urihttps://hdl.handle.net/10668/27621
dc.identifier.wosID700527703067
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS1111-S1111
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleREGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía